Research topic
Secretagogue Research
Growth-hormone releasing pathways in endocrine research models.
Mechanism background
Secretagogue-class peptides, such as GHRH analogues and GHRP-family fragments, are studied for their interaction with the pituitary somatotroph axis and their effect on downstream growth-hormone secretory pathways.
What's typically measured
Research protocols commonly assess receptor-binding kinetics, pulsatile secretion patterns in endocrine cell models, and combination effects when GHRH and GHRP-class compounds are studied together.
Literature themes
A notable area of ongoing study is the comparative half-life and receptor selectivity of truncated GHRH fragments relative to full-length analogues.
Key terms
- GHRH
- Growth-hormone releasing hormone; the hypothalamic signal that stimulates somatotroph cells in the pituitary.
- GHRP
- Growth-hormone releasing peptide; a separate class acting through the ghrelin receptor rather than the GHRH receptor.
- Somatotroph
- The pituitary cell type that produces and secretes growth hormone.
Handling and storage
Secretagogue peptides degrade faster in solution than most other classes here. Published protocols commonly reconstitute immediately before use and discard working solutions after 24 hours at 4°C.
Research use only. This page summarises published research themes for laboratory context. It is not guidance for human or veterinary use, and nothing here is intended to diagnose, treat, cure or prevent any disease.